How does peptide ordering work on White Label Rx?

Peptide programs are wide. Beyond the headline molecules like sermorelin and NAD+, clinics order a long tail of compounds, and not every 503A pharmacy makes every peptide. That turns ordering into two questions: how deep is the catalog you can actually reach, and how cleanly does a multi-SKU order route when different molecules live behind different compounders. White Label Rx connects you to 503A pharmacies that compound peptides, but the specific molecules, concentrations, and rates depend on the partner network, so confirm catalog breadth directly rather than assuming any single peptide is stocked.

This page is about ordering workflow, not clinical protocols. Which peptides a clinic offers is a prescriber and program decision; the platform's job is to surface what is available, route each line to the right pharmacy, and show what each costs. What you should evaluate is whether the platform exposes a deep, searchable catalog with repeat-SKU favorites and clean multi-pharmacy routing.

The first pitfall is catalog uncertainty: White Label Rx does not publish its peptide formulary on whitelblrx.com, so confirm exactly which molecules are available and from which partner before you build a menu around them. The second is multi-SKU friction: a peptide order that spans several compounders can become several submissions, and a single rejected line can hold up the rest. The third is pricing — White Label Rx's public FAQ directs clinics to a custom quote, so per-vial peptide rates are not visible up front.

Fizy Health is the same multi-pharmacy 503A category but builds around these pressure points. A searchable medication catalog spans assigned compounders, catalog favorites speed reordering of the molecules you use most, a single checkout routes each line to the right partner, and per-vial 503A cost shows before checkout. Where White Label Rx publishes no catalog detail, treat it as a demo question rather than an assumption.